文献速递中医内科中药与中成药合理使用

中草药治疗慢性肾脏病的机制与疗效

Mechanisms and Efficacy of Chinese Herbal Medicines in Chronic Kidney Disease.
PubMed 文献 · Front Pharmacol · 2021-03-29

综述汇总同行评议英文期刊文献,聚焦常用中草药在肾病中的抗炎、抗氧化、抗凋亡、自噬介导与抗纤维化作用,并讨论近年临床试验与荟萃分析。部分设计良好的随机对照试验与荟萃分析显示,中草药作为常规药物辅助治疗可能使慢性肾脏病患者获益。

要点

  • 中草药可能通过抗炎、抗氧化、抗凋亡、自噬介导与抗纤维化发挥肾脏保护作用
  • 作为常规药物的辅助治疗,中草药可能使慢性肾脏病患者获益
  • 有效成分不明、部分试验质量低与样本量小、安全性问题限制其发展

核心结论

  • 中草药是治疗慢性肾脏病的一种潜在方法
  • 仍需进一步研究机制并开展设计良好的随机对照试验评价疗效与安全性

研究设计与样本

  • 综述基于同行评议英文期刊文献,聚焦肾病常用中草药的抗炎、抗氧化、抗凋亡、自噬介导与抗纤维化作用
  • 结合近年发表的临床试验与荟萃分析进行讨论

主要发现

  • 体内与体外肾病机制研究显示,中草药具有抗炎、抗氧化、抗凋亡、自噬介导与抗纤维化作用
  • 部分设计良好的随机对照试验与荟萃分析显示,中草药作为常规药物辅助治疗可能使慢性肾脏病患者获益

临床怎么用

  • 可考虑将中草药作为常规药物的辅助治疗用于慢性肾脏病患者,但需关注其安全性

局限性

  • 部分中草药有效成分不明
  • 部分临床试验质量低、样本量小
  • 中草药的安全性尚待明确

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

As the current treatment of chronic kidney disease (CKD) is limited, it is necessary to seek more effective and safer treatment methods, such as Chinese herbal medicines (CHMs). In order to clarify the modern theoretical basis and molecular mechanisms of CHMs, we reviewed the knowledge based on publications in peer-reviewed English-language journals, focusing on the anti-inflammatory, antioxidative, anti-apoptotic, autophagy-mediated and antifibrotic effects of CHMs commonly used in kidney disease. We also discussed recently published clinical trials and meta-analyses in this field. Based on recent studies regarding the mechanisms of kidney disease in vivo and in vitro, CHMs have anti-inflammatory, antioxidative, anti-apoptotic, autophagy-mediated, and antifibrotic effects. Several well-designed randomized controlled trials (RCTs) and meta-analyses demonstrated that the use of CHMs as an adjuvant to conventional medicines may benefit patients with CKD. Unknown active ingredients, low quality and small sample sizes of some clinical trials, and the safety of CHMs have restricted the development of CHMs. CHMs is a potential method in the treatment of CKD. Further study on the mechanism and well-conducted RCTs are urgently needed to evaluate the efficacy and safety of CHMs.

来源:Front Pharmacol,查看原文。版权归原作者所有。

引用

  1. Zhao M, Yu Y, Wang R, et al. Mechanisms and Efficacy of Chinese Herbal Medicines in Chronic Kidney Disease. Front Pharmacol. 2021. PMID: 33854427. doi:10.3389/fphar.2020.619201

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。